BLMN three-lens brief
Evidence-based stock research on BLMN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -4.09% yesterday. · Trading >3% below the 50-day MA — short-term weakness.
- Moved -4.09% yesterday.
- Trading >3% below the 50-day MA — short-term weakness.
- Analyst mean target $11.32 — 31% above current (11 analysts).
- Debt-to-equity of 442% — balance-sheet-heavy.
BLMN closed at $8.67 (-4.09%) as of 2026-09-11. Market cap: $742.33M. P/E (trailing) 28.0. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $11.32 — 31% above current (11 analysts).. Concerns: moved -4.09% yesterday.; trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $1.02B, net income $31.34M, free cash flow $276.19M.
Why three lenses on BLMN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BLMNacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BLMN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BLMN brief"></iframe>